Combining Cell Type-Restricted Adenoviral Targeting with Immunostaining and Flow Cytometry to Identify Cells-of-Origin of Lung Cancer
Overview
Affiliations
Lung cancers display considerable intertumoral heterogeneity, leading to the classification of distinct tumor subtypes. Our understanding of the genetic aberrations that underlie tumor subtypes has been greatly enhanced by recent genomic sequencing studies and state-of-the-art gene targeting technologies, highlighting evidence that distinct lung cancer subtypes may be derived from different "cells-of-origin". Here, we describe the intra-tracheal delivery of cell type-restricted Ad5-Cre viruses into the lungs of adult mice, combined with immunohistochemical and flow cytometry strategies for the detection of lung cancer-initiating cells in vivo.
McDonald J, Scott L, Van Zuylekom J, Holloway S, Blyth B, Sutherland K Methods Mol Biol. 2023; 2691:31-41.
PMID: 37355535 DOI: 10.1007/978-1-0716-3331-1_3.
Gangoda L, Schenk R, Best S, Nedeva C, Louis C, DSilva D Cell Death Differ. 2021; 29(1):96-104.
PMID: 34304242 PMC: 8738744. DOI: 10.1038/s41418-021-00839-3.
Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis.
Best S, Vandenberg C, Abad E, Whitehead L, Guiu L, Ding S Cell Death Dis. 2020; 11(10):877.
PMID: 33082333 PMC: 7575595. DOI: 10.1038/s41419-020-03066-9.
Best S, Ding S, Kersbergen A, Dong X, Song J, Xie Y Nat Commun. 2019; 10(1):4190.
PMID: 31519898 PMC: 6744438. DOI: 10.1038/s41467-019-12164-y.
Studying the immune landscape in lung cancer models: choosing the right experimental tools.
Weeden C, Ah-Cann C, Asselin-Labat M Transl Lung Cancer Res. 2018; 7(Suppl 3):S248-S250.
PMID: 30393614 PMC: 6193919. DOI: 10.21037/tlcr.2018.09.05.